Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Xgeva

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



diabetes-related kidney failure1 - hexagonal crystals1 - de toni-fanconi-debré syndrome1 - cmaj2 - screening test1 - lower urinary tract symptom score1 - metabolic syndrome1 - hemodiafiltration1 - urinary urgency incontinence1 - hesitancy2 - function of dialysis1 - ectopic pregnancy2 - itraconazole1 - secondary tumor1 - standard kidney biopsy1 - asn14 - gonococcal infections1 - radiation therapy oncology group1 - hepatolenticular degeneration1 - urethral diverticulum1 - hyperactivity disorder1 - urinary tract infections8 - prostate cancer foundation3 - urinary stones symptoms1 - anorexia1 - diuretics1 - urinary ions2 - psa screening7 - prostate cancer drug2 - low carbohydrate diet1 -